A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)

NCT02996019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Etrolizumab
DEVICE: Auto-Injector (AI)
DEVICE: Prefilled Syringe With Needle Safety Device (PFS-NSD)

Sponsor

Genentech, Inc.